Clinical Trials

    Showing 1 - 1 of 1 Atherosclerosis and Arteriosclerosis

    Status: Enrolling

    Investigator: Sadeer Al-Kindi

    Study Coordinator: Hira Saleem

    Phone: 346.238.0307

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the h... Read more >